← Leaderboards
Thomas Ray Moench
Reprotect, Inc.
$3,137,722
Attributed
$3,137,722
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.7M · FY2010–23$5M$3.8M$2.5M$1.3M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$25,846,496 · 8
By mechanism
U19$15,523,238 · 2
P50$5,722,859 · 1
U54$2,000,000 · 1
R33$1,622,042 · 1
R61$606,012 · 1
R41$372,345 · 2
Top collaborators
- Deborah J Anderson12 shared
- Kevin John Whaley12 shared
Others in their field
Top investigators on “Vaginal Ring”
- Myron S Cohen · Family Health International$91,263,426
- Wafaa M. El-Sadr · Columbia University Health Sciences$91,263,426
- Sharon L Hillier · Magee-Women'S Hospital Of Upmc$67,249,846
- Elizabeth Renata Brown · Fred Hutchinson Cancer Center$31,139,823
- Thomas J. Smith · Control Delivery Systems, Inc.$16,353,154
- Lisa C Rohan · Magee-Women'S Hospital Of Upmc$9,788,755
Research focus
Vaginal RingVaginaDosePreventAntibodiesMonoclonal AntibodiesBasePathogenSafetyIn VitroSurfaceCostWomanImmunoglobulin GTechnologyMicrobicideProductionProgramsPharmaceutical PreparationsPreventionMucous Body SubstanceFilmIn VivoMucins
Grant awards (25)
Nonhormonal contraceptive intravaginal ring based on high valency anti-sperm antibody constructs$535,972
R33 · FY2023 · HD · contact PI
Nonhormonal contraceptive intravaginal ring based on high valency anti-sperm antibody constructs$540,726
R33 · FY2022 · HD · contact PI
Antibody-based Contraceptive MPTs: Preclinical and Clinical Research$1,813,579
P50 · FY2021 · HD
Nonhormonal contraceptive intravaginal ring based on high valency anti-sperm antibody constructs$545,344
R33 · FY2021 · HD · contact PI
Antibody-based Contraceptive MPTs: Preclinical and Clinical Research$1,867,062
P50 · FY2020 · HD
Nonhormonal contraceptive intravaginal ring based on high valency anti-sperm antibody constructs$310,245
R61 · FY2020 · HD · contact PI
Antibody-based Contraceptive MPTs: Preclinical and Clinical Research$2,042,218
P50 · FY2019 · HD
Nonhormonal contraceptive intravaginal ring based on high valency anti-sperm antibody constructs$295,767
R61 · FY2019 · HD · contact PI
Antibody-based Contraceptive MPTs: Preclinical and Clinical Research$2,000,000
U54 · FY2018 · HD
Delivery of pathogen-trapping antibodies for vaginal protection$50,000
R41 · FY2017 · AI · contact PI
Monoclonal Antibody-based Multipurpose Microbicides$288,303
U19 · FY2016 · AI
Delivery of pathogen-trapping antibodies for vaginal protection$222,725
R41 · FY2016 · AI · contact PI
Monoclonal Antibody-based Multipurpose Microbicides$2,408,349
U19 · FY2015 · AI
Vaginal mAB Delivery Systems$67,600
U19 · FY2015 · AI · contact PI
Monoclonal Antibody-based Multipurpose Microbicides$2,530,562
U19 · FY2014 · AI
Vaginal mAB Delivery Systems$56,560
U19 · FY2014 · AI · contact PI
Monoclonal Antibody-based Multipurpose Microbicides$27,182
U19 · FY2014 · AI
Monoclonal Antibody-based Multipurpose Microbicides$3,098,297
U19 · FY2013 · AI
Vaginal mAB Delivery Systems$78,500
U19 · FY2013 · AI · contact PI
Monoclonal Antibody-based Multipurpose Microbicides$3,573,839
U19 · FY2012 · AI
Vaginal mAB Delivery Systems$97,600
U19 · FY2012 · AI · contact PI
Monoclonal Antibody-based Multipurpose Microbicides$26,134
U19 · FY2012 · AI
Monoclonal Antibody-based Multipurpose Microbicides$3,033,249
U19 · FY2011 · AI
Vaginal mAB Delivery Systems$237,063
U19 · FY2011 · AI · contact PI
Vaginal Ring for Preventing Bacterial Vaginosis$99,620
R41 · FY2010 · HD · contact PI